Nevertheless, single blockage of VISTA was insufficient to reduce tumor growth compared to a simultaneous blockage of CTLA-4 and VISTA [59], recommending combined ICP-targeting in HNSCC. This evidence concerns the gene VSIR and head and neck squamous cell carcinoma.